Academic Journal
Q1Nature Reviews Gastroenterology and Hepatology
About Nature Reviews Gastroenterology and Hepatology
Nature Reviews Gastroenterology and Hepatology is a scholarly journal published by Nature Research. SCImago 2025 places it in Q1 with an SJR of 9.982 and an H-index of 236.
Its listed coverage is 2009-2026 and its research categories include Gastroenterology (Q1); Hepatology (Q1). The 2025 dataset reports 133 documents and 8655 citations across the latest three-year reporting window.
Nature Reviews Gastroenterology & Hepatology is a highly respected, peer-reviewed medical journal that focuses on the latest developments in the fields of gastroenterology and hepatology. Published by Nature Portfolio, this journal provides cutting-edge reviews, expert opinions, and in-depth analyses of key topics related to digestive system disorders, liver diseases, and advancements in medical research.
About Nature Reviews Gastroenterology & Hepatology
Established as a leading source of information for healthcare professionals, researchers, and clinicians, Nature Reviews Gastroenterology & Hepatology covers a wide range of topics, including:- Gastrointestinal diseases such as irritable bowel syndrome (IBS), Crohn’s disease, and colorectal cancer
- Liver diseases including cirrhosis, hepatitis, and fatty liver disease
- Advances in endoscopy and diagnostic techniques
- Microbiome research and its role in gut health
- Latest treatment strategies and clinical trials
Why Nature Reviews Gastroenterology & Hepatology Stands Out
1. Expert-Driven Content
The journal publishes content written and reviewed by leading gastroenterologists, hepatologists, and researchers from around the world. This ensures that the information provided is accurate, reliable, and based on the latest scientific data.2. High Impact Factor
As one of the most cited journals in its field, Nature Reviews Gastroenterology & Hepatology boasts a high impact factor, reflecting its influence and credibility in the medical community.3. Comprehensive Reviews and Analyses
Unlike original research journals, this publication focuses on high-quality reviews, offering in-depth discussions of clinical advancements, emerging trends, and future directions in digestive health research.4. Global Reach and Accessibility
The journal is widely accessible to medical professionals across the globe, offering both print and digital formats. This ensures that the latest knowledge reaches a broad audience, contributing to improved patient care and medical education.Latest Trends in Gastroenterology and Hepatology
Recent topics covered by Nature Reviews Gastroenterology & Hepatology include:- Gut Microbiome and Disease – Exploring the role of gut bacteria in conditions like IBS and metabolic disorders.
- Liver Regeneration Research – Breakthroughs in regenerative medicine for treating liver diseases.
- Personalized Medicine – Advancements in genetic profiling for tailored treatments in digestive disorders.
- Artificial Intelligence in Gastroenterology – The use of AI and machine learning in diagnostics and treatment planning.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Nature Reviews Gastroenterology & Hepatology is a premier, high-impact journal dedicated to the fields of gastroenterology and hepatology. As part of the prestigious Nature Reviews portfolio, this journal publishes authoritative and insightful articles that encompass the latest research, reviews, and expert opinions in digestive health, liver diseases, and associated disorders.
Scope of the Journal
Nature Reviews Gastroenterology & Hepatology covers a broad spectrum of topics within gastroenterology and hepatology. The journal focuses on key areas such as:- Gastrointestinal Disorders – Includes research and reviews on conditions like irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and peptic ulcers.
- Liver Diseases – Encompasses topics like hepatitis, cirrhosis, fatty liver disease, hepatocellular carcinoma, and liver transplantation.
- Pancreatic and Biliary Diseases – Covers pancreatic cancer, pancreatitis, gallstones, and bile duct diseases.
- Gut Microbiome and Nutrition – Explores the role of gut microbiota, probiotics, and dietary interventions in gastrointestinal health.
- Advanced Diagnostic and Therapeutic Techniques – Features insights into endoscopy, imaging technologies, minimally invasive procedures, and emerging treatment strategies.
Nature of the Content
The journal is renowned for publishing high-quality, peer-reviewed content that includes:Comprehensive Reviews
These in-depth articles provide critical analysis and synthesis of the latest findings in gastroenterology and hepatology, helping readers stay updated with advancements in the field.Expert Opinions
Commentary pieces from leading experts offer insights into emerging trends, challenges, and future directions in digestive and liver health.Research Highlights
Summaries of groundbreaking studies from across the globe offer readers a snapshot of innovative research and clinical advancements.Clinical and Translational Updates
Bridging the gap between research and clinical application, these articles provide valuable information for practitioners, aiding in patient care and treatment strategies.SEO and Online Visibility
To enhance discoverability and reach a wider audience, Nature Reviews Gastroenterology & Hepatology optimizes its content for search engines through:- Keyword Optimization – Using relevant terms like “gastroenterology research,” “hepatology journal,” and “digestive health studies.”
- High-Quality Backlinks – Collaborating with leading institutions and researchers to improve authority and credibility.
- Mobile-Friendly Content – Ensuring accessibility across various devices to reach global readers.
- Engaging Meta Descriptions – Crafting compelling summaries that improve click-through rates on search engine results pages (SERPs).
Recent Research Articles
Latest publications matched automatically by ISSN.
Beyond inflammation: the residual burden as the next target in inflammatory bowel disease
Brigida Barberio, Shaji Sebastian, Alexander C. Ford, Beatriz Gros et al.
2026-09-09 · DOI: 10.1038/s41575-026-01259-9Heart–liver co-management in MASLD: expert perspectives and recommendations from a multidisciplinary cardiometabolic framework
Xiao-Dong Zhou, Seogsong Jeong, Qin-Fen Chen, Giovanni Targher et al.
2026-09-09 · DOI: 10.1038/s41575-026-01255-zBuilding and regenerating intestines by manipulating intestinal stem cells
Calvin J. Kuo, Sarah Blutt, Mark Donowitz, Mary K. Estes et al.
2026-09-03 · DOI: 10.1038/s41575-026-01242-4Challenges and opportunities in combining radiotherapy and immunotherapy for localized pancreatic cancer
Gilles Colin, Sylvie Streel, Eric Deutsch, Lorenzo Galluzzi et al.
2026-09-02 · DOI: 10.1038/s41575-026-01250-4Long non-coding RNAs in colorectal cancer: shaping the tumour microenvironment and advancing precision oncology
M. Bartolini, F. Battaglin, S. Soni, S. Algaze et al.
2026-09-01 · DOI: 10.1038/s41575-026-01243-3Closing the policy gap: including children in the global agenda for steatotic liver disease
Samannay Das, Tamoghna Biswas
2026-08-26 · DOI: 10.1038/s41575-026-01253-1Reply to ‘Closing the policy gap: including children in the global agenda for steatotic liver disease’
Jeffrey V. Lazarus, Bruno Halpern, Peter E. H. Schwarz, Veronica Miller et al.
2026-08-26 · DOI: 10.1038/s41575-026-01252-2The International Chinese Young Scholars Alliance for the Study of the Liver: facilitating global collaboration
Wenhao Li, Zhujun Cao, Yee Hui Yeo, Ying Shang et al.
2026-08-25 · DOI: 10.1038/s41575-026-01256-yThe microbial mirror: how a disrupted microbiome forecasts disease and why policy must act
Antonio Gasbarrini, Gianluca Ianiro, Giovanni Gasbarrini
2026-08-24 · DOI: 10.1038/s41575-026-01246-0Phase I trial of faecal microbiome transplantation for food allergy
Katrina Ray
2026-08-20 · DOI: 10.1038/s41575-026-01254-0Sexual dimorphism in the liver
Anisha Jain, Satdarshan P. Monga
2026-08-19 · DOI: 10.1038/s41575-026-01244-2Relieving IBD with duvakitug
Katrina Ray
2026-08-18 · DOI: 10.1038/s41575-026-01251-3Noninvasive testing for fibrosis and cirrhosis in MASLD
Katrina Ray
2026-08-18 · DOI: 10.1038/s41575-026-01247-zFrom researcher to CEO: closing the gap between discovery and delivery
Jelena Mann
2026-08-18 · DOI: 10.1038/s41575-026-01249-xGlobal epidemiology of metabolic and alcohol-associated liver disease: risk factors, natural history and clinical implications
Luis Antonio Díaz, Elisa Pose, Mads Israelsen, Rohit Loomba et al.
2026-08-18 · DOI: 10.1038/s41575-026-01240-6Viral pyroptosis linked to lethal hepatic lipid accumulation
Katrina Ray
2026-08-14 · DOI: 10.1038/s41575-026-01248-yAuthor Correction: The dynamic spectrum of steatotic liver disease: the global perspective
Zobair M. Younossi, Shira Zelber-Sagi, Markos Kalligeros, Dana Ivancovsky Wajcman et al.
2026-08-14 · DOI: 10.1038/s41575-026-01245-1The dynamic spectrum of steatotic liver disease: the global perspective
Zobair M. Younossi, Shira Zelber-Sagi, Markos Kalligeros, Dana Ivancovsky Wajcman et al.
2026-08-07 · DOI: 10.1038/s41575-026-01235-3Multidisciplinary Delphi consensus statement on minimal standards for clinical metadata and end points in microbiome studies
Robert Schierwagen, Federica Carraturo, Anandhi Iyappan, Maximilian J. Brol et al.
2026-08-03 · DOI: 10.1038/s41575-026-01229-1Mechanisms, management and prevention of anorectal sexually transmitted infections
Phyu Mon Latt, Fabian Y. S. Kong, Christine M. Khosropour, Ming J. Lee et al.
2026-07-31 · DOI: 10.1038/s41575-026-01232-6Reviews
Community Reviews
Version History
April 16, 2025 at 10:22 am
March 26, 2025